Karo Pharma AB (publ)
Get $10 bonus on your first $100 deposit for KARBF
Get $10 bonus on your first $100 deposit for KARBF
Karo Pharma AB (publ) (KARBF) Stock Competitors & Peer Comparison
See (KARBF) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| KARBF | $5.25 | +0.00% | 1.5B | 262.50 | $0.02 | N/A |
| IPSEY | $48.54 | +0.00% | 64.2B | 31.73 | $1.53 | +0.82% |
| MKKGY | $26.20 | +0.15% | 57B | 19.00 | $1.38 | +1.92% |
| MKGAF | $136.21 | -0.12% | 55.8B | 18.58 | $6.91 | +1.95% |
| TKPHF | $34.52 | +0.00% | 54.5B | 78.45 | $0.44 | +3.39% |
| HLNCF | $4.89 | -1.31% | 43.6B | 20.40 | $0.24 | +3.21% |
| SDZNY | $84.40 | +2.02% | 36.5B | 40.36 | $2.09 | +0.86% |
| TEVJF | $28.36 | +0.00% | 33B | 23.44 | $1.21 | N/A |
| SGIOF | $21.85 | -3.45% | 18.6B | 17.34 | $1.26 | +1.77% |
| TAIPY | $14.00 | +16.67% | 18.1B | 82.35 | $0.17 | N/A |
Stock Comparison
KARBF vs IPSEY Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, IPSEY has a market cap of 64.2B. Regarding current trading prices, KARBF is priced at $5.25, while IPSEY trades at $48.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas IPSEY's P/E ratio is 31.73. In terms of profitability, KARBF's ROE is N/A, compared to IPSEY's ROE of +0.10%. Regarding short-term risk, KARBF is less volatile compared to IPSEY. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check IPSEY's competition here
KARBF vs MKKGY Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, MKKGY has a market cap of 57B. Regarding current trading prices, KARBF is priced at $5.25, while MKKGY trades at $26.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas MKKGY's P/E ratio is 19.00. In terms of profitability, KARBF's ROE is N/A, compared to MKKGY's ROE of +0.09%. Regarding short-term risk, KARBF is less volatile compared to MKKGY. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check MKKGY's competition here
KARBF vs MKGAF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, MKGAF has a market cap of 55.8B. Regarding current trading prices, KARBF is priced at $5.25, while MKGAF trades at $136.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas MKGAF's P/E ratio is 18.58. In terms of profitability, KARBF's ROE is N/A, compared to MKGAF's ROE of +0.09%. Regarding short-term risk, KARBF is less volatile compared to MKGAF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check MKGAF's competition here
KARBF vs TKPHF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, TKPHF has a market cap of 54.5B. Regarding current trading prices, KARBF is priced at $5.25, while TKPHF trades at $34.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas TKPHF's P/E ratio is 78.45. In terms of profitability, KARBF's ROE is N/A, compared to TKPHF's ROE of +0.02%. Regarding short-term risk, KARBF is less volatile compared to TKPHF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check TKPHF's competition here
KARBF vs HLNCF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, HLNCF has a market cap of 43.6B. Regarding current trading prices, KARBF is priced at $5.25, while HLNCF trades at $4.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas HLNCF's P/E ratio is 20.40. In terms of profitability, KARBF's ROE is N/A, compared to HLNCF's ROE of +0.06%. Regarding short-term risk, KARBF is less volatile compared to HLNCF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check HLNCF's competition here
KARBF vs SDZNY Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, SDZNY has a market cap of 36.5B. Regarding current trading prices, KARBF is priced at $5.25, while SDZNY trades at $84.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas SDZNY's P/E ratio is 40.36. In terms of profitability, KARBF's ROE is N/A, compared to SDZNY's ROE of +0.08%. Regarding short-term risk, KARBF is less volatile compared to SDZNY. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check SDZNY's competition here
KARBF vs TEVJF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, TEVJF has a market cap of 33B. Regarding current trading prices, KARBF is priced at $5.25, while TEVJF trades at $28.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas TEVJF's P/E ratio is 23.44. In terms of profitability, KARBF's ROE is N/A, compared to TEVJF's ROE of +0.20%. Regarding short-term risk, KARBF and TEVJF have similar daily volatility (0.00).Check TEVJF's competition here
KARBF vs SGIOF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, SGIOF has a market cap of 18.6B. Regarding current trading prices, KARBF is priced at $5.25, while SGIOF trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas SGIOF's P/E ratio is 17.34. In terms of profitability, KARBF's ROE is N/A, compared to SGIOF's ROE of +0.14%. Regarding short-term risk, KARBF is less volatile compared to SGIOF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check SGIOF's competition here
KARBF vs TAIPY Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, TAIPY has a market cap of 18.1B. Regarding current trading prices, KARBF is priced at $5.25, while TAIPY trades at $14.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas TAIPY's P/E ratio is 82.35. In terms of profitability, KARBF's ROE is N/A, compared to TAIPY's ROE of +0.02%. Regarding short-term risk, KARBF is less volatile compared to TAIPY. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check TAIPY's competition here
KARBF vs SGIOY Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, SGIOY has a market cap of 18B. Regarding current trading prices, KARBF is priced at $5.25, while SGIOY trades at $10.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas SGIOY's P/E ratio is 16.82. In terms of profitability, KARBF's ROE is N/A, compared to SGIOY's ROE of +0.14%. Regarding short-term risk, KARBF is less volatile compared to SGIOY. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check SGIOY's competition here
KARBF vs ESALY Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, ESALY has a market cap of 17.6B. Regarding current trading prices, KARBF is priced at $5.25, while ESALY trades at $61.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas ESALY's P/E ratio is 20.54. In terms of profitability, KARBF's ROE is N/A, compared to ESALY's ROE of +0.06%. Regarding short-term risk, KARBF is less volatile compared to ESALY. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check ESALY's competition here
KARBF vs BIOVF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, BIOVF has a market cap of 13.8B. Regarding current trading prices, KARBF is priced at $5.25, while BIOVF trades at $39.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas BIOVF's P/E ratio is 284.79. In terms of profitability, KARBF's ROE is N/A, compared to BIOVF's ROE of +0.01%. Regarding short-term risk, KARBF is less volatile compared to BIOVF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check BIOVF's competition here
KARBF vs IPSEF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, IPSEF has a market cap of 9.4B. Regarding current trading prices, KARBF is priced at $5.25, while IPSEF trades at $113.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas IPSEF's P/E ratio is 18.07. In terms of profitability, KARBF's ROE is N/A, compared to IPSEF's ROE of +0.12%. Regarding short-term risk, KARBF is less volatile compared to IPSEF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check IPSEF's competition here
KARBF vs ESAIY Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, ESAIY has a market cap of 9B. Regarding current trading prices, KARBF is priced at $5.25, while ESAIY trades at $7.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas ESAIY's P/E ratio is 29.19. In terms of profitability, KARBF's ROE is N/A, compared to ESAIY's ROE of +0.05%. Regarding short-term risk, KARBF is less volatile compared to ESAIY. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check ESAIY's competition here
KARBF vs ESALF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, ESALF has a market cap of 8.5B. Regarding current trading prices, KARBF is priced at $5.25, while ESALF trades at $30.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas ESALF's P/E ratio is 27.27. In terms of profitability, KARBF's ROE is N/A, compared to ESALF's ROE of +0.05%. Regarding short-term risk, KARBF is less volatile compared to ESALF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check ESALF's competition here
KARBF vs SFOSF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, SFOSF has a market cap of 7.1B. Regarding current trading prices, KARBF is priced at $5.25, while SFOSF trades at $2.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas SFOSF's P/E ratio is 14.21. In terms of profitability, KARBF's ROE is N/A, compared to SFOSF's ROE of +0.09%. Regarding short-term risk, KARBF is less volatile compared to SFOSF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check SFOSF's competition here
KARBF vs GZPHF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, GZPHF has a market cap of 6.2B. Regarding current trading prices, KARBF is priced at $5.25, while GZPHF trades at $2.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas GZPHF's P/E ratio is 9.00. In terms of profitability, KARBF's ROE is N/A, compared to GZPHF's ROE of +0.08%. Regarding short-term risk, KARBF and GZPHF have similar daily volatility (0.00).Check GZPHF's competition here
KARBF vs LVZPF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, LVZPF has a market cap of 6.1B. Regarding current trading prices, KARBF is priced at $5.25, while LVZPF trades at $5.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas LVZPF's P/E ratio is 15.35. In terms of profitability, KARBF's ROE is N/A, compared to LVZPF's ROE of +0.15%. Regarding short-term risk, KARBF is less volatile compared to LVZPF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check LVZPF's competition here
KARBF vs HLUBF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, HLUBF has a market cap of 4.8B. Regarding current trading prices, KARBF is priced at $5.25, while HLUBF trades at $4.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas HLUBF's P/E ratio is 9.64. In terms of profitability, KARBF's ROE is N/A, compared to HLUBF's ROE of +0.13%. Regarding short-term risk, KARBF is less volatile compared to HLUBF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check HLUBF's competition here
KARBF vs HLBBF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, HLBBF has a market cap of 4.7B. Regarding current trading prices, KARBF is priced at $5.25, while HLBBF trades at $5.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas HLBBF's P/E ratio is 11.57. In terms of profitability, KARBF's ROE is N/A, compared to HLBBF's ROE of +0.13%. Regarding short-term risk, KARBF and HLBBF have similar daily volatility (0.00).Check HLBBF's competition here
KARBF vs SMDPY Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, SMDPY has a market cap of 4.7B. Regarding current trading prices, KARBF is priced at $5.25, while SMDPY trades at $11.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas SMDPY's P/E ratio is 4.82. In terms of profitability, KARBF's ROE is N/A, compared to SMDPY's ROE of +0.49%. Regarding short-term risk, KARBF is less volatile compared to SMDPY. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check SMDPY's competition here
KARBF vs DNPUF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, DNPUF has a market cap of 4.4B. Regarding current trading prices, KARBF is priced at $5.25, while DNPUF trades at $11.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas DNPUF's P/E ratio is 4.55. In terms of profitability, KARBF's ROE is N/A, compared to DNPUF's ROE of +0.49%. Regarding short-term risk, KARBF is less volatile compared to DNPUF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check DNPUF's competition here
KARBF vs SGFEF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, SGFEF has a market cap of 4.4B. Regarding current trading prices, KARBF is priced at $5.25, while SGFEF trades at $100.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas SGFEF's P/E ratio is 20.88. In terms of profitability, KARBF's ROE is N/A, compared to SGFEF's ROE of +0.16%. Regarding short-term risk, KARBF is less volatile compared to SGFEF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check SGFEF's competition here
KARBF vs HKMPY Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, HKMPY has a market cap of 3.9B. Regarding current trading prices, KARBF is priced at $5.25, while HKMPY trades at $35.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas HKMPY's P/E ratio is 9.77. In terms of profitability, KARBF's ROE is N/A, compared to HKMPY's ROE of +0.16%. Regarding short-term risk, KARBF and HKMPY have similar daily volatility (0.00).Check HKMPY's competition here
KARBF vs HKMPF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, HKMPF has a market cap of 3.8B. Regarding current trading prices, KARBF is priced at $5.25, while HKMPF trades at $17.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas HKMPF's P/E ratio is 9.56. In terms of profitability, KARBF's ROE is N/A, compared to HKMPF's ROE of +0.16%. Regarding short-term risk, KARBF is less volatile compared to HKMPF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check HKMPF's competition here
KARBF vs APNHF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, APNHF has a market cap of 3.6B. Regarding current trading prices, KARBF is priced at $5.25, while APNHF trades at $8.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas APNHF's P/E ratio is -34.17. In terms of profitability, KARBF's ROE is N/A, compared to APNHF's ROE of -0.02%. Regarding short-term risk, KARBF is less volatile compared to APNHF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check APNHF's competition here
KARBF vs APNHY Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, APNHY has a market cap of 3.6B. Regarding current trading prices, KARBF is priced at $5.25, while APNHY trades at $8.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas APNHY's P/E ratio is -33.71. In terms of profitability, KARBF's ROE is N/A, compared to APNHY's ROE of -0.02%. Regarding short-term risk, KARBF and APNHY have similar daily volatility (0.00).Check APNHY's competition here
KARBF vs HYPMY Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, HYPMY has a market cap of 3.3B. Regarding current trading prices, KARBF is priced at $5.25, while HYPMY trades at $4.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas HYPMY's P/E ratio is 13.05. In terms of profitability, KARBF's ROE is N/A, compared to HYPMY's ROE of +0.10%. Regarding short-term risk, KARBF is less volatile compared to HYPMY. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check HYPMY's competition here
KARBF vs LBTSF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, LBTSF has a market cap of 3.3B. Regarding current trading prices, KARBF is priced at $5.25, while LBTSF trades at $15.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas LBTSF's P/E ratio is 61.40. In terms of profitability, KARBF's ROE is N/A, compared to LBTSF's ROE of +0.04%. Regarding short-term risk, KARBF and LBTSF have similar daily volatility (0.00).Check LBTSF's competition here
KARBF vs CHSYF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, CHSYF has a market cap of 3.3B. Regarding current trading prices, KARBF is priced at $5.25, while CHSYF trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas CHSYF's P/E ratio is 13.50. In terms of profitability, KARBF's ROE is N/A, compared to CHSYF's ROE of +0.09%. Regarding short-term risk, KARBF is less volatile compared to CHSYF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check CHSYF's competition here
KARBF vs INVVY Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, INVVY has a market cap of 3B. Regarding current trading prices, KARBF is priced at $5.25, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas INVVY's P/E ratio is -62.42. In terms of profitability, KARBF's ROE is N/A, compared to INVVY's ROE of -0.99%. Regarding short-term risk, KARBF and INVVY have similar daily volatility (0.00).Check INVVY's competition here
KARBF vs IZQVF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, IZQVF has a market cap of 2.9B. Regarding current trading prices, KARBF is priced at $5.25, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, KARBF's ROE is N/A, compared to IZQVF's ROE of -0.99%. Regarding short-term risk, KARBF and IZQVF have similar daily volatility (0.00).Check IZQVF's competition here
KARBF vs ULIHF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, ULIHF has a market cap of 2.6B. Regarding current trading prices, KARBF is priced at $5.25, while ULIHF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas ULIHF's P/E ratio is 8.13. In terms of profitability, KARBF's ROE is N/A, compared to ULIHF's ROE of +0.13%. Regarding short-term risk, KARBF is less volatile compared to ULIHF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check ULIHF's competition here
KARBF vs HMDCF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, HMDCF has a market cap of 2.4B. Regarding current trading prices, KARBF is priced at $5.25, while HMDCF trades at $2.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas HMDCF's P/E ratio is 5.32. In terms of profitability, KARBF's ROE is N/A, compared to HMDCF's ROE of +0.41%. Regarding short-term risk, KARBF is less volatile compared to HMDCF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check HMDCF's competition here
KARBF vs DMPHF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, DMPHF has a market cap of 2.1B. Regarding current trading prices, KARBF is priced at $5.25, while DMPHF trades at $39.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas DMPHF's P/E ratio is 17.90. In terms of profitability, KARBF's ROE is N/A, compared to DMPHF's ROE of +0.20%. Regarding short-term risk, KARBF is less volatile compared to DMPHF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check DMPHF's competition here
KARBF vs NPNKF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, NPNKF has a market cap of 2.1B. Regarding current trading prices, KARBF is priced at $5.25, while NPNKF trades at $31.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas NPNKF's P/E ratio is 10.57. In terms of profitability, KARBF's ROE is N/A, compared to NPNKF's ROE of +0.11%. Regarding short-term risk, KARBF is less volatile compared to NPNKF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check NPNKF's competition here
KARBF vs HTSUF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, HTSUF has a market cap of 2B. Regarding current trading prices, KARBF is priced at $5.25, while HTSUF trades at $29.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas HTSUF's P/E ratio is 16.76. In terms of profitability, KARBF's ROE is N/A, compared to HTSUF's ROE of +0.07%. Regarding short-term risk, KARBF and HTSUF have similar daily volatility (0.00).Check HTSUF's competition here
KARBF vs NPPNY Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, NPPNY has a market cap of 2B. Regarding current trading prices, KARBF is priced at $5.25, while NPPNY trades at $7.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas NPPNY's P/E ratio is 10.00. In terms of profitability, KARBF's ROE is N/A, compared to NPPNY's ROE of +0.12%. Regarding short-term risk, KARBF is less volatile compared to NPPNY. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check NPPNY's competition here
KARBF vs ARSUF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, ARSUF has a market cap of 1.9B. Regarding current trading prices, KARBF is priced at $5.25, while ARSUF trades at $26.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas ARSUF's P/E ratio is 18.55. In terms of profitability, KARBF's ROE is N/A, compared to ARSUF's ROE of +0.17%. Regarding short-term risk, KARBF is less volatile compared to ARSUF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check ARSUF's competition here
KARBF vs DUTV Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, DUTV has a market cap of 1.9B. Regarding current trading prices, KARBF is priced at $5.25, while DUTV trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas DUTV's P/E ratio is N/A. In terms of profitability, KARBF's ROE is N/A, compared to DUTV's ROE of -0.04%. Regarding short-term risk, KARBF is less volatile compared to DUTV. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check DUTV's competition here
KARBF vs CURLF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, CURLF has a market cap of 1.8B. Regarding current trading prices, KARBF is priced at $5.25, while CURLF trades at $2.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas CURLF's P/E ratio is -7.20. In terms of profitability, KARBF's ROE is N/A, compared to CURLF's ROE of -0.29%. Regarding short-term risk, KARBF is less volatile compared to CURLF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check CURLF's competition here
KARBF vs TSMRF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, TSMRF has a market cap of 1.7B. Regarding current trading prices, KARBF is priced at $5.25, while TSMRF trades at $23.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas TSMRF's P/E ratio is 10.04. In terms of profitability, KARBF's ROE is N/A, compared to TSMRF's ROE of +0.10%. Regarding short-term risk, KARBF is less volatile compared to TSMRF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check TSMRF's competition here
KARBF vs SHPHF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, SHPHF has a market cap of 1.7B. Regarding current trading prices, KARBF is priced at $5.25, while SHPHF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas SHPHF's P/E ratio is -6.22. In terms of profitability, KARBF's ROE is N/A, compared to SHPHF's ROE of +0.03%. Regarding short-term risk, KARBF and SHPHF have similar daily volatility (0.00).Check SHPHF's competition here
KARBF vs MITPF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, MITPF has a market cap of 1.6B. Regarding current trading prices, KARBF is priced at $5.25, while MITPF trades at $23.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas MITPF's P/E ratio is -10.81. In terms of profitability, KARBF's ROE is N/A, compared to MITPF's ROE of +4.99%. Regarding short-term risk, KARBF is less volatile compared to MITPF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check MITPF's competition here
KARBF vs GTBIF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, GTBIF has a market cap of 1.6B. Regarding current trading prices, KARBF is priced at $5.25, while GTBIF trades at $6.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas GTBIF's P/E ratio is 13.81. In terms of profitability, KARBF's ROE is N/A, compared to GTBIF's ROE of +0.06%. Regarding short-term risk, KARBF is less volatile compared to GTBIF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check GTBIF's competition here
KARBF vs CHIZF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, CHIZF has a market cap of 1.4B. Regarding current trading prices, KARBF is priced at $5.25, while CHIZF trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas CHIZF's P/E ratio is -27.34. In terms of profitability, KARBF's ROE is N/A, compared to CHIZF's ROE of -0.01%. Regarding short-term risk, KARBF and CHIZF have similar daily volatility (0.00).Check CHIZF's competition here
KARBF vs CASBF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, CASBF has a market cap of 1.3B. Regarding current trading prices, KARBF is priced at $5.25, while CASBF trades at $3.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas CASBF's P/E ratio is -38.60. In terms of profitability, KARBF's ROE is N/A, compared to CASBF's ROE of +0.01%. Regarding short-term risk, KARBF is less volatile compared to CASBF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check CASBF's competition here
KARBF vs SWGHF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, SWGHF has a market cap of 1.3B. Regarding current trading prices, KARBF is priced at $5.25, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas SWGHF's P/E ratio is 15.57. In terms of profitability, KARBF's ROE is N/A, compared to SWGHF's ROE of +0.05%. Regarding short-term risk, KARBF and SWGHF have similar daily volatility (0.00).Check SWGHF's competition here
KARBF vs TCNNF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, TCNNF has a market cap of 1.2B. Regarding current trading prices, KARBF is priced at $5.25, while TCNNF trades at $6.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas TCNNF's P/E ratio is -10.77. In terms of profitability, KARBF's ROE is N/A, compared to TCNNF's ROE of -0.10%. Regarding short-term risk, KARBF is less volatile compared to TCNNF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check TCNNF's competition here
KARBF vs LJUIF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, LJUIF has a market cap of 1.2B. Regarding current trading prices, KARBF is priced at $5.25, while LJUIF trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas LJUIF's P/E ratio is 13.42. In terms of profitability, KARBF's ROE is N/A, compared to LJUIF's ROE of +0.06%. Regarding short-term risk, KARBF is less volatile compared to LJUIF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check LJUIF's competition here
KARBF vs BIOGY Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, BIOGY has a market cap of 1.1B. Regarding current trading prices, KARBF is priced at $5.25, while BIOGY trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas BIOGY's P/E ratio is 31.43. In terms of profitability, KARBF's ROE is N/A, compared to BIOGY's ROE of +0.24%. Regarding short-term risk, KARBF and BIOGY have similar daily volatility (0.00).Check BIOGY's competition here
KARBF vs KSPHF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, KSPHF has a market cap of 1.1B. Regarding current trading prices, KARBF is priced at $5.25, while KSPHF trades at $25.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas KSPHF's P/E ratio is 12.04. In terms of profitability, KARBF's ROE is N/A, compared to KSPHF's ROE of +0.07%. Regarding short-term risk, KARBF is less volatile compared to KSPHF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check KSPHF's competition here
KARBF vs GNMLF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, GNMLF has a market cap of 1.1B. Regarding current trading prices, KARBF is priced at $5.25, while GNMLF trades at $1.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas GNMLF's P/E ratio is 12.00. In terms of profitability, KARBF's ROE is N/A, compared to GNMLF's ROE of +0.11%. Regarding short-term risk, KARBF is less volatile compared to GNMLF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check GNMLF's competition here
KARBF vs KKPCF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, KKPCF has a market cap of 984.6M. Regarding current trading prices, KARBF is priced at $5.25, while KKPCF trades at $26.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas KKPCF's P/E ratio is 288.89. In terms of profitability, KARBF's ROE is N/A, compared to KKPCF's ROE of -0.03%. Regarding short-term risk, KARBF is less volatile compared to KKPCF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check KKPCF's competition here
KARBF vs EVOTF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, EVOTF has a market cap of 930.6M. Regarding current trading prices, KARBF is priced at $5.25, while EVOTF trades at $5.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas EVOTF's P/E ratio is -7.71. In terms of profitability, KARBF's ROE is N/A, compared to EVOTF's ROE of -0.12%. Regarding short-term risk, KARBF is less volatile compared to EVOTF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check EVOTF's competition here
KARBF vs TWAPF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, TWAPF has a market cap of 828.5M. Regarding current trading prices, KARBF is priced at $5.25, while TWAPF trades at $16.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas TWAPF's P/E ratio is 6.28. In terms of profitability, KARBF's ROE is N/A, compared to TWAPF's ROE of +0.12%. Regarding short-term risk, KARBF is less volatile compared to TWAPF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check TWAPF's competition here
KARBF vs NIKA Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, NIKA has a market cap of 785M. Regarding current trading prices, KARBF is priced at $5.25, while NIKA trades at $0.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas NIKA's P/E ratio is N/A. In terms of profitability, KARBF's ROE is N/A, compared to NIKA's ROE of +0.29%. Regarding short-term risk, KARBF and NIKA have similar daily volatility (0.00).Check NIKA's competition here
KARBF vs CSWYF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, CSWYF has a market cap of 758.4M. Regarding current trading prices, KARBF is priced at $5.25, while CSWYF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas CSWYF's P/E ratio is 4.78. In terms of profitability, KARBF's ROE is N/A, compared to CSWYF's ROE of +0.20%. Regarding short-term risk, KARBF is less volatile compared to CSWYF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check CSWYF's competition here
KARBF vs TRXPF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, TRXPF has a market cap of 690.7M. Regarding current trading prices, KARBF is priced at $5.25, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, KARBF's ROE is N/A, compared to TRXPF's ROE of +0.03%. Regarding short-term risk, KARBF and TRXPF have similar daily volatility (0.00).Check TRXPF's competition here
KARBF vs SHEZF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, SHEZF has a market cap of 689M. Regarding current trading prices, KARBF is priced at $5.25, while SHEZF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas SHEZF's P/E ratio is -23.48. In terms of profitability, KARBF's ROE is N/A, compared to SHEZF's ROE of +0.01%. Regarding short-term risk, KARBF is less volatile compared to SHEZF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check SHEZF's competition here
KARBF vs YIHCF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, YIHCF has a market cap of 643.1M. Regarding current trading prices, KARBF is priced at $5.25, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, KARBF's ROE is N/A, compared to YIHCF's ROE of +0.06%. Regarding short-term risk, KARBF and YIHCF have similar daily volatility (0.00).Check YIHCF's competition here
KARBF vs GLASF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, GLASF has a market cap of 634.9M. Regarding current trading prices, KARBF is priced at $5.25, while GLASF trades at $8.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas GLASF's P/E ratio is -14.91. In terms of profitability, KARBF's ROE is N/A, compared to GLASF's ROE of -0.23%. Regarding short-term risk, KARBF is less volatile compared to GLASF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check GLASF's competition here
KARBF vs AIHLF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, AIHLF has a market cap of 624.3M. Regarding current trading prices, KARBF is priced at $5.25, while AIHLF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas AIHLF's P/E ratio is 10.94. In terms of profitability, KARBF's ROE is N/A, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, KARBF and AIHLF have similar daily volatility (0.00).Check AIHLF's competition here
KARBF vs TRSSF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, TRSSF has a market cap of 601.9M. Regarding current trading prices, KARBF is priced at $5.25, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, KARBF's ROE is N/A, compared to TRSSF's ROE of -0.68%. Regarding short-term risk, KARBF is less volatile compared to TRSSF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check TRSSF's competition here
KARBF vs AGYTF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, AGYTF has a market cap of 554.6M. Regarding current trading prices, KARBF is priced at $5.25, while AGYTF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas AGYTF's P/E ratio is -11.00. In terms of profitability, KARBF's ROE is N/A, compared to AGYTF's ROE of +2.84%. Regarding short-term risk, KARBF and AGYTF have similar daily volatility (0.00).Check AGYTF's competition here
KARBF vs PKBFF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, PKBFF has a market cap of 544.7M. Regarding current trading prices, KARBF is priced at $5.25, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas PKBFF's P/E ratio is N/A. In terms of profitability, KARBF's ROE is N/A, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, KARBF and PKBFF have similar daily volatility (0.00).Check PKBFF's competition here
KARBF vs KHTRF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, KHTRF has a market cap of 538.6M. Regarding current trading prices, KARBF is priced at $5.25, while KHTRF trades at $5.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas KHTRF's P/E ratio is -137.35. In terms of profitability, KARBF's ROE is N/A, compared to KHTRF's ROE of -0.01%. Regarding short-term risk, KARBF is less volatile compared to KHTRF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check KHTRF's competition here
KARBF vs CCHWF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, CCHWF has a market cap of 521.3M. Regarding current trading prices, KARBF is priced at $5.25, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, KARBF's ROE is N/A, compared to CCHWF's ROE of +0.42%. Regarding short-term risk, KARBF is less volatile compared to CCHWF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check CCHWF's competition here
KARBF vs BOIRF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, BOIRF has a market cap of 520.9M. Regarding current trading prices, KARBF is priced at $5.25, while BOIRF trades at $30.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas BOIRF's P/E ratio is 22.73. In terms of profitability, KARBF's ROE is N/A, compared to BOIRF's ROE of +0.05%. Regarding short-term risk, KARBF and BOIRF have similar daily volatility (0.00).Check BOIRF's competition here
KARBF vs VRNOF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, VRNOF has a market cap of 470.4M. Regarding current trading prices, KARBF is priced at $5.25, while VRNOF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas VRNOF's P/E ratio is -1.31. In terms of profitability, KARBF's ROE is N/A, compared to VRNOF's ROE of -0.30%. Regarding short-term risk, KARBF is less volatile compared to VRNOF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check VRNOF's competition here
KARBF vs HUMDF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, HUMDF has a market cap of 466.1M. Regarding current trading prices, KARBF is priced at $5.25, while HUMDF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas HUMDF's P/E ratio is 2.95. In terms of profitability, KARBF's ROE is N/A, compared to HUMDF's ROE of +1.07%. Regarding short-term risk, KARBF is less volatile compared to HUMDF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check HUMDF's competition here
KARBF vs PEXXF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, PEXXF has a market cap of 463.1M. Regarding current trading prices, KARBF is priced at $5.25, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, KARBF's ROE is N/A, compared to PEXXF's ROE of N/A. Regarding short-term risk, KARBF and PEXXF have similar daily volatility (0.00).Check PEXXF's competition here
KARBF vs ELTP Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, ELTP has a market cap of 407.9M. Regarding current trading prices, KARBF is priced at $5.25, while ELTP trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas ELTP's P/E ratio is 9.47. In terms of profitability, KARBF's ROE is N/A, compared to ELTP's ROE of +0.71%. Regarding short-term risk, KARBF is less volatile compared to ELTP. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check ELTP's competition here
KARBF vs SWDCF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, SWDCF has a market cap of 399.6M. Regarding current trading prices, KARBF is priced at $5.25, while SWDCF trades at $2.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas SWDCF's P/E ratio is 62.50. In terms of profitability, KARBF's ROE is N/A, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, KARBF is less volatile compared to SWDCF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check SWDCF's competition here
KARBF vs CPHRF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, CPHRF has a market cap of 341.2M. Regarding current trading prices, KARBF is priced at $5.25, while CPHRF trades at $13.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas CPHRF's P/E ratio is 12.79. In terms of profitability, KARBF's ROE is N/A, compared to CPHRF's ROE of +0.24%. Regarding short-term risk, KARBF and CPHRF have similar daily volatility (0.00).Check CPHRF's competition here
KARBF vs CRLBF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, CRLBF has a market cap of 315.4M. Regarding current trading prices, KARBF is priced at $5.25, while CRLBF trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas CRLBF's P/E ratio is -2.42. In terms of profitability, KARBF's ROE is N/A, compared to CRLBF's ROE of -0.33%. Regarding short-term risk, KARBF is less volatile compared to CRLBF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check CRLBF's competition here
KARBF vs PROCF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, PROCF has a market cap of 230.4M. Regarding current trading prices, KARBF is priced at $5.25, while PROCF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas PROCF's P/E ratio is -0.15. In terms of profitability, KARBF's ROE is N/A, compared to PROCF's ROE of -2.24%. Regarding short-term risk, KARBF is less volatile compared to PROCF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check PROCF's competition here
KARBF vs BHCCF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, BHCCF has a market cap of 225.1M. Regarding current trading prices, KARBF is priced at $5.25, while BHCCF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas BHCCF's P/E ratio is -4.57. In terms of profitability, KARBF's ROE is N/A, compared to BHCCF's ROE of +0.29%. Regarding short-term risk, KARBF is less volatile compared to BHCCF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check BHCCF's competition here
KARBF vs PLNHF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, PLNHF has a market cap of 202M. Regarding current trading prices, KARBF is priced at $5.25, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, KARBF's ROE is N/A, compared to PLNHF's ROE of +659479.06%. Regarding short-term risk, KARBF is less volatile compared to PLNHF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check PLNHF's competition here
KARBF vs PHCUF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, PHCUF has a market cap of 188.1M. Regarding current trading prices, KARBF is priced at $5.25, while PHCUF trades at $7.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas PHCUF's P/E ratio is -707.00. In terms of profitability, KARBF's ROE is N/A, compared to PHCUF's ROE of -0.00%. Regarding short-term risk, KARBF is less volatile compared to PHCUF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check PHCUF's competition here
KARBF vs SHIEF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, SHIEF has a market cap of 134.6M. Regarding current trading prices, KARBF is priced at $5.25, while SHIEF trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas SHIEF's P/E ratio is -6.30. In terms of profitability, KARBF's ROE is N/A, compared to SHIEF's ROE of +1.40%. Regarding short-term risk, KARBF is less volatile compared to SHIEF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check SHIEF's competition here
KARBF vs LOVFF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, LOVFF has a market cap of 133.5M. Regarding current trading prices, KARBF is priced at $5.25, while LOVFF trades at $1.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas LOVFF's P/E ratio is 15.48. In terms of profitability, KARBF's ROE is N/A, compared to LOVFF's ROE of +0.12%. Regarding short-term risk, KARBF is less volatile compared to LOVFF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check LOVFF's competition here
KARBF vs COPHF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, COPHF has a market cap of 131.7M. Regarding current trading prices, KARBF is priced at $5.25, while COPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas COPHF's P/E ratio is -0.02. In terms of profitability, KARBF's ROE is N/A, compared to COPHF's ROE of -5.75%. Regarding short-term risk, KARBF is less volatile compared to COPHF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check COPHF's competition here
KARBF vs CBWTF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, CBWTF has a market cap of 126.4M. Regarding current trading prices, KARBF is priced at $5.25, while CBWTF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas CBWTF's P/E ratio is 4.51. In terms of profitability, KARBF's ROE is N/A, compared to CBWTF's ROE of +0.23%. Regarding short-term risk, KARBF is less volatile compared to CBWTF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check CBWTF's competition here
KARBF vs NWPN Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, NWPN has a market cap of 123.7M. Regarding current trading prices, KARBF is priced at $5.25, while NWPN trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas NWPN's P/E ratio is -0.04. In terms of profitability, KARBF's ROE is N/A, compared to NWPN's ROE of +0.13%. Regarding short-term risk, KARBF is less volatile compared to NWPN. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check NWPN's competition here
KARBF vs BIOYF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, BIOYF has a market cap of 121.5M. Regarding current trading prices, KARBF is priced at $5.25, while BIOYF trades at $10.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas BIOYF's P/E ratio is 18.88. In terms of profitability, KARBF's ROE is N/A, compared to BIOYF's ROE of +0.23%. Regarding short-term risk, KARBF is less volatile compared to BIOYF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check BIOYF's competition here
KARBF vs LPCUF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, LPCUF has a market cap of 112.1M. Regarding current trading prices, KARBF is priced at $5.25, while LPCUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas LPCUF's P/E ratio is 9.51. In terms of profitability, KARBF's ROE is N/A, compared to LPCUF's ROE of +0.06%. Regarding short-term risk, KARBF is less volatile compared to LPCUF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check LPCUF's competition here
KARBF vs CNVCF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, CNVCF has a market cap of 109.2M. Regarding current trading prices, KARBF is priced at $5.25, while CNVCF trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas CNVCF's P/E ratio is -5.00. In terms of profitability, KARBF's ROE is N/A, compared to CNVCF's ROE of +1.21%. Regarding short-term risk, KARBF and CNVCF have similar daily volatility (0.00).Check CNVCF's competition here
KARBF vs HLTRF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, HLTRF has a market cap of 100.4M. Regarding current trading prices, KARBF is priced at $5.25, while HLTRF trades at $3.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas HLTRF's P/E ratio is -8.23. In terms of profitability, KARBF's ROE is N/A, compared to HLTRF's ROE of -0.19%. Regarding short-term risk, KARBF is less volatile compared to HLTRF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check HLTRF's competition here
KARBF vs JUSHF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, JUSHF has a market cap of 100M. Regarding current trading prices, KARBF is priced at $5.25, while JUSHF trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas JUSHF's P/E ratio is -1.43. In terms of profitability, KARBF's ROE is N/A, compared to JUSHF's ROE of +0.76%. Regarding short-term risk, KARBF is less volatile compared to JUSHF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check JUSHF's competition here
KARBF vs ORXOY Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, ORXOY has a market cap of 97.2M. Regarding current trading prices, KARBF is priced at $5.25, while ORXOY trades at $2.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas ORXOY's P/E ratio is -2.24. In terms of profitability, KARBF's ROE is N/A, compared to ORXOY's ROE of +5.65%. Regarding short-term risk, KARBF and ORXOY have similar daily volatility (0.00).Check ORXOY's competition here
KARBF vs CWBHF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, CWBHF has a market cap of 92.6M. Regarding current trading prices, KARBF is priced at $5.25, while CWBHF trades at $0.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas CWBHF's P/E ratio is -3.05. In terms of profitability, KARBF's ROE is N/A, compared to CWBHF's ROE of -2.75%. Regarding short-term risk, KARBF is less volatile compared to CWBHF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check CWBHF's competition here
KARBF vs MEDXF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, MEDXF has a market cap of 92.1M. Regarding current trading prices, KARBF is priced at $5.25, while MEDXF trades at $2.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas MEDXF's P/E ratio is -142.50. In terms of profitability, KARBF's ROE is N/A, compared to MEDXF's ROE of -0.01%. Regarding short-term risk, KARBF is less volatile compared to MEDXF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check MEDXF's competition here
KARBF vs AAWH Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, AAWH has a market cap of 91M. Regarding current trading prices, KARBF is priced at $5.25, while AAWH trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas AAWH's P/E ratio is -0.78. In terms of profitability, KARBF's ROE is N/A, compared to AAWH's ROE of -14.10%. Regarding short-term risk, KARBF is less volatile compared to AAWH. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check AAWH's competition here
KARBF vs ABSCF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, ABSCF has a market cap of 90.7M. Regarding current trading prices, KARBF is priced at $5.25, while ABSCF trades at $1.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas ABSCF's P/E ratio is -8.06. In terms of profitability, KARBF's ROE is N/A, compared to ABSCF's ROE of +0.33%. Regarding short-term risk, KARBF is less volatile compared to ABSCF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check ABSCF's competition here
KARBF vs ORXOF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, ORXOF has a market cap of 79.4M. Regarding current trading prices, KARBF is priced at $5.25, while ORXOF trades at $2.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas ORXOF's P/E ratio is -1.86. In terms of profitability, KARBF's ROE is N/A, compared to ORXOF's ROE of +5.65%. Regarding short-term risk, KARBF is less volatile compared to ORXOF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check ORXOF's competition here
KARBF vs EOFBY Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, EOFBY has a market cap of 73.7M. Regarding current trading prices, KARBF is priced at $5.25, while EOFBY trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas EOFBY's P/E ratio is -7.67. In terms of profitability, KARBF's ROE is N/A, compared to EOFBY's ROE of -0.77%. Regarding short-term risk, KARBF and EOFBY have similar daily volatility (0.00).Check EOFBY's competition here
KARBF vs GRUSF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, GRUSF has a market cap of 72.1M. Regarding current trading prices, KARBF is priced at $5.25, while GRUSF trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas GRUSF's P/E ratio is 28.90. In terms of profitability, KARBF's ROE is N/A, compared to GRUSF's ROE of +0.00%. Regarding short-term risk, KARBF is less volatile compared to GRUSF. This indicates potentially lower risk in terms of short-term price fluctuations for KARBF.Check GRUSF's competition here
KARBF vs GDNSF Comparison April 2026
KARBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KARBF stands at 1.5B. In comparison, GDNSF has a market cap of 61M. Regarding current trading prices, KARBF is priced at $5.25, while GDNSF trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KARBF currently has a P/E ratio of 262.50, whereas GDNSF's P/E ratio is -2.66. In terms of profitability, KARBF's ROE is N/A, compared to GDNSF's ROE of -0.69%. Regarding short-term risk, KARBF and GDNSF have similar daily volatility (0.00).Check GDNSF's competition here